A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy
NCT05577390
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Diabetic peripheral neuropathy is one of the most common and costly microvascular complications of diabetes impacting more than 50% of patients and costing more than 10.1 billion dollars annually. Intraneural Facilitation Therapy (INF® Therapy) is a non-invasive technique that has shown to improve balance and pain in patients with Type 2 Diabetic Peripheral Neuropathy (T2DPN); however, the underlying physiological mechanisms need further understanding.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Peripheral Neuropathy With Type 2 Diabetes
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 45 to 85 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Loma Linda University
- Last updated on ClinicalTrials.gov
- November 19, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Loma Linda University Health Neuropathic Therapy Center · Loma Linda, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.